Synbodies to Akt1

The present application provides synbodies against AKT1 differing in amino acid sequence, conjugation chemistry, linker/scaffold, or adjunct moiety. The synbodies are useful for diagnosis and treatment of cancer and as research reagents.

Attached files:
WO 2011029008.jpg

Patents:
WO 2,011,029,008

Inventor(s): JOHNSTON STEPHEN [US]; DIEHNELT CHRIS [US]; GUPTA NIDHI [US]; BELCHER PAUL [US]

Type of Offer: Licensing



Next Patent »
« More Biotech Patents

Share on      


CrowdSell Your Patent